Huajian Medical, based in Hong Kong, suspended its purchase of Ethereum worth approximately 3 billion yuan following delays in obtaining shareholder approval. This indicates significant challenges in large-scale cryptocurrency acquisitions under regulatory frameworks.
The suspension may influence Huajian’s stock and illustrates a trend of traditional companies exploring Ethereum amidst stringent regulations. Currently, Ethereum is priced at 3,868.25 USD, with a 24-hour trading volume decrease of 18.71% and a 90-day increase of 5.93%.
Leave a Reply